HCR76

2022 Regular Session

HCR76 by Representative Tammy Phelps

HEALTH/SICKLE CELL ANEM: Expresses support for equitable access to transformative therapies for sickle cell disease

Current Status: Sent to the Secretary of State

Text

Resume Digest for HCR76

Digest of HCR76 Engrossed

Digest of HCR76 Original

Senate Vote on HCR 76 CONCUR (#753)

House Vote on HCR 76 FINAL CONSIDERATION (#592)

Tammy Phelps (primary)

Date	Chamber	Journal Page	Action
05/26	H		Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.
05/25	S	61	Signed by the President of the Senate.
05/24	H	39	Enrolled and signed by the Speaker of the House.
05/23	H	32	Received from the Senate without amendments.
05/23	S	29	Read by title and concurred in by a vote of 37 yeas and 0 nays. Ordered returned to the House.
05/18	S	8	Reported favorably.
05/09	S	11	Read second time by title and referred to the Committee on Health and Welfare.
05/04	S	6	Received in the Senate. Read first time by title and placed on the Calendar for a second reading.
05/03	H	18	Read by title, roll called on final consideration, yeas 93, nays 0. The resolution was adopted and ordered to the Senate.
05/03	H	18	Called from the calendar.
05/03	H	18	Read by title, returned to the calendar.
04/28	H		Scheduled for floor debate on 05/03/2022.
04/28	H	5	Read by title, ordered engrossed, passed to 3rd reading.
04/27	H	38	Reported favorably (10-1).
04/21	H	3	Read by title, under the rules, referred to the Committee on Health and Welfare.
04/20	H	2	Read by title. Lies over under the rules.